Duodenal-type follicular lymphoma (DFL) are uncommon, presenting in both symptomatic and asymptomatic patients, and are generally associated with a benign clinical course. Treatment options include surgery, radiation, and chemotherapy. However, many patients can be managed conservatively with little to no treatment, as 5-year progression-free survival is greater than 70%, and 5-year overall survival ranges from 80% to 94%. Here, we present a case of incidental DFL in a patient with metabolic dysfunction-associated steatohepatitis and cirrhosis. A review of the endoscopic and histologic characteristics, as well as epidemiology, risk factors, and long-term outcomes, may guide management strategies when DFL is encountered.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075945 | PMC |
| http://dx.doi.org/10.14309/crj.0000000000001358 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Duodenal Polyposis: An Incidental Finding of Duodenal-Type Follicular Lymphoma.
Cureus
November 2024
Gastroenterology and Hepatology, Yale New Haven Hospital, New Haven, USA.
Article Synopsis
- - Duodenal-type follicular lymphoma is a rare variant of follicular lymphoma that generally has a good prognosis and can be asymptomatic or present with vague gastrointestinal symptoms.
- - Diagnosis often happens incidentally during an endoscopic procedure (EGD) when biopsies of duodenal polyps are taken.
- - A unique case of biopsy-confirmed duodenal-type B cell follicular lymphoma was treated with localized radiotherapy, resulting in complete remission after six months; physicians need to be aware of this rare condition and the possibility of systemic B-cell lymphoma involvement.
Clinical characteristics and outcomes of Brazilian patients with duodenal-type follicular lymphoma: a multicenter retrospective study.
Leuk Lymphoma
January 2025
Rede Dor Sao Luiz, Sao Paulo, Brazil.
Duodenal-type follicular lymphoma (DFL) is a rare subtype classified by the 5th edition of the WHO and international consensus classifications of lymphoid neoplasms, typically presenting as localized disease with favorable outcomes. This multicenter retrospective study examines 53 Brazilian DFL patients with a median age of 58.2 years (33-85), with males comprising 50% ( = 27).
View Article and Find Full Text PDFDuodenal-type follicular lymphoma: comprehensive insights into disease characteristics and established treatment strategies.
Curr Opin Oncol
November 2024
Department of Hematology, Stem Cell Transplant and Cellular Therapy, Oncology Centre.
Purpose Of Review: This review aims to detail the characteristics and outcomes of duodenal-type follicular lymphoma (DTFL), a rare lymphoma variant. It focuses on integrating recent reports in treatment modalities and highlights emerging insights into the unique biological features of the disease.
Recent Finding: Recent studies confirm the indolent nature of DTFL, with extended follow-up periods showing favorable outcomes under watchful waiting strategies and a notable proportion of patients experiencing spontaneous remission.
Duodenal-Type Follicular Lymphoma.
Gastro Hep Adv
July 2023
Department of Internal Medicine, King Hamad University Hospital, Busaiteen, Muharraq, Kingdom of Bahrain.
This case report presents the clinical findings, diagnostic evaluation, and treatment options for a 71-year-old female patient with a medical history of hypertension, dyslipidemia, and recurrent urinary tract infections. The patient presented with chronic abdominal pain as the sole symptom. Despite normal laboratory investigations, esophagogastroduodenoscopy and ileocolonoscopy were performed.
View Article and Find Full Text PDFEndoscopic resection of a primary duodenal-type follicular lymphoma.
Asian J Surg
July 2024
Department of Gastroenterology, Nanjing Pukou People's Hospital, Nanjing, China. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!